Background And Aim Of The Study: High-risk patients referred for aortic valve replacement (AVR) may benefit from sutureless technology in order to reduce mortality and morbidity. Herein is described the authors' initial experience and short-term results of the sutureless 3f Enable aortic bioprosthesis.
Methods: A total of 28 patients (19 females, nine males; mean age 76.